ZymoGenetics’ Atacicept Will Enter Phase II/III For Lupus Nephritis In Q4
Company and partner Merck Serono also are working with FDA to finalize protocol for study in general systemic lupus erythematosus.
Company and partner Merck Serono also are working with FDA to finalize protocol for study in general systemic lupus erythematosus.